FAQs | Site Map | Links | Home
January 13, 2009
skip navigation

  arrow Bill Tracking

  (spacer) Legislative Updates

  (spacer) Public Laws

  (spacer) Hearings

  (spacer) Committees of
   (spacer) Interest to NIH


  (spacer) OLPA


margin frame

Bill TrackingBill Tracking
(spacer)

Senate Bills - 110th Congress

arrow indicating current page Session I | Session II

S. 2569—The Ovarian Cancer Biomarker Research Act

On January 29, 2008, Senator Barbara Boxer (D-CA), introduced S. 2569, the Ovarian Cancer Biomarker Research Act. The bill would amend Title IV of the PHS Act to require NCI to make awards for the establishment of centers to conduct research on biomarkers for ovarian cancer. The bill also requires the establishment of the Ovarian Cancer Biomarker Clinical Trial Committee to assist in the design and implementation of one or more national clinical trials to determine the utility of using biomarkers validated as a result of the research conducted by the centers. The companion measure, H.R. 3689, was introduced by Representative Howard Berman (D-CA) on September 27, 2007. S. 2569 was referred to the Senate Committee on Health, Education, Labor, and Pensions (HELP).

Legislative Update (March 2008): Ovarian Cancer Biomarker Act

(spacer)

 

Privacy | Accessibility | Disclaimer    

National Institutes of Health Department of Health and Human Services USA.gov - Government Made Easy